Improving Inhaler Technique Through Pharmacy
This service is commissioned by GMHSCP. Relaunched April 2021.
Provider List: Inhaler Technique Service Provider List June 21.xlsx
Below you will find links to a range of documents to support service delivery in your pharmacy
Service Overview: Inhaler Technique Service Overview 270521 v01
(Please Note: This is a template SOP which you can adapt for use in your particular pharmacy. It should be reviewed in conjunction with the service specification) agreed and signed off by your pharmacy superintendent before implementation. Pharmacists providing the service must be familiar with the service specification before providing the service)
Training: GM Healthcare Academy Webinar
Performance Management: KPI's and Monthly RAG reports
PSNC: Video Conferencing
Documents and Resources To Support Delivery
Poster: Check your Inhaler Technique
Great for printing and displaying in the consultation room. Contains a selection of videos showing the correct technique for specific devices. Accessed via QR code.
CPD modules from CPPE. Various e-modules are available to support Declaration of Competence, including:
CPD modules from Primary Care Respiratory Academy
These CPD e-modules from the Primary Care Respiratory Academy will help support Declaration of Competence. You can access them all at http://www.respiratoryacademy.co.uk/clinical-resources/cpd-modules/ and they cover: Inhaler devices; Supported self-management in COPD; Management of comorbidities in asthma; Management of comorbidities in COPD; Smoking cessation; Spirometry; Acute exacerbations of COPD; Supported asthma self-management; Childhood wheeze; and The value of tests in respiratory disease.
The Primary Care Respiratory Academy has been developed and produced by Cogora, working in partnership with the Primary Care Respiratory Society UK (PCRS-UK) with endorsement from the British Lung Foundation. Cogora publish Pulse, Nursing in Practice and Healthcare Leader. The initiative is supported by funding from Pfizer, on behalf of the Novartis-Pfizer Alliance, and from Napp Pharmaceuticals.